Dr. Andrea Galmozzi is a faculty member of the Division of Endocrinology, Diabetes and Metabolism within the Department of Medicine. Throughout his training, he has published 22 peer-reviewed articles; he was a recipient of various awards, including Italian Institute of Health and American Heart Association predoctoral and postdoctoral fellowships, respectively. In 2019, was invited to present at the Rising Stars Lecture Series at NIH. Dr. Galmozzi serves as reviewer for several peer-reviewed scientific journals.
View Dr. Andrea Galmozzi's publications on NCBI MyBibliography
Dr. Galmozzi’s research focuses on the identification of adipocyte functional pathways that can be pharmacologically modulated to treat metabolic disorders, including obesity and type 2 diabetes. His primary research interest is to understand how signaling metabolites, particularly endogenous ligands of nuclear receptors, are trafficked inside cells. He carries out this goal using a multidisciplinary approach encompassing physiology, chemical biology (chemoproteomics, metabolomics), molecular and cellular biology, and in vivo models of metabolic disease. Elucidation of the molecular pathways that traffic signaling metabolites will shed light on the crosstalk between metabolism and gene transcription, reveal fundamental mechanisms in cell biology and open up new avenues to modulate gene expression for therapeutic purposes.